Mindray Medical also provided a disappointing full-year 2015 outlook. Net revenue growth is expected in low-single-digit (down from the previous guidance of mid-single digits) over the 2014 figure.

Mindray said the solid showing was driven by strong sales in China and key emerging markets, 10 new products and a nice lift from acquisitions. It expects 2013 revenue to rise at least 17% vs. a ...

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, today announced selected preliminary, unaudited results for the fiscal year ...

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, announced today an agreement to acquire a controlling stake of Shenzhen Shenke ...

SHENZHEN, China, Jan. 20, 2020 /PRNewswire/ -- Mindray Medical (SZSE: 300760), a leading global provider of medical devices and solutions, announces the release of its new Point-of-Care Ultrasound ...

Chinese medical device maker Mindray Medical today said it planned to buy Datascope's patient monitoring business for $202 million in cash. Datascope is based in Montvale, and is a leading ...

SHENZHEN, China, Oct. 23, 2023 /PRNewswire/ -- Mindray (SZSE: 300760), a global leader in medical devices and solutions, introduces high-sensitivi ...

Biotech. Cell & Gene Therapy; Clinical Data; Venture Capital; Devices; Diagnostics; AI and Machine Learning; CRO; Special Reports ...